Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.8M Buy
16,531
+798
+5% +$82.8K 0.81% 36
2023
Q3
$1.62M Buy
15,733
+327
+2% +$35.2K 0.94% 31
2023
Q2
$1.78M Sell
15,406
-67
-0.4% -$7.61K 1% 24
2023
Q1
$1.65M Sell
15,473
-1,384
-8% -$149K 0.95% 27
2022
Q4
$1.87M Sell
16,857
-1,243
-7% -$127K 1.04% 23
2022
Q3
$1.56M Sell
18,100
-58
-0.3% -$5.18K 0.88% 31
2022
Q2
$1.66M Sell
18,158
-297
-2% -$26.3K 0.89% 30
2022
Q1
$1.6M Buy
18,455
+560
+3% +$44.2K 0.75% 36
2021
Q4
$1.34M Hold
17,895
0.71% 44
2021
Q3
$1.34M Buy
17,895
+425
+2% +$32.3K 0.71% 44
2021
Q2
$1.36M Sell
17,470
-405
-2% -$30.1K 0.77% 41
2021
Q1
$1.31M Sell
17,875
-608
-3% -$44.8K 0.81% 31
2020
Q4
$1.44M Buy
+18,483
New +$1.41M 1% 28
2020
Q2
$1.38M Buy
18,738
+471
+3% +$35.5K 1.23% 19
2020
Q1
$1.34M Buy
18,267
+512
+3% +$40.2K 1.47% 17
2019
Q4
$1.54M Buy
+17,755
New +$1.46M 1.37% 16

Other funds holding MRK

Columbia Trust's MRK Position: Q4 2023 in Review

Columbia Trust increased its Merck (MRK) stake by 5.1% in Q4 2023, buying an estimated $82.8K and bringing the position to 16,531 shares worth $1.8M. The position accounts for 0.81% of the portfolio, ranked #36.

Columbia Trust first reported a position in MRK in Q4 2019 and has held it in 16 quarters since. The position peaked at $1.87M in Q4 2022. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Columbia Trust held 16,531 shares of Merck worth $1.8M as of Q4 2023.
  • Columbia Trust bought 798 Merck shares in Q4 2023, an estimated $82.8K.
  • Merck made up 0.81% of Columbia Trust's portfolio in Q4 2023, its #36 holding.
  • Columbia Trust first reported a position in Merck in Q4 2019 and has held it in 16 quarters since.
  • Columbia Trust's Merck position peaked at $1.87M in Q4 2022.
  • 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Columbia Trust's 13F filing for Q4 2023, filed 17 Jan 2024.